I'm uploading a new picture.

it is a case study and a question is in the end of picture

ALL QUESTIONS RELATE TO THE FOLLOWING SCENARIO: Aussie Pharmaceuticals Led (AP) is Australia's largest pharmaceutical company, which employs over 10,000 workers. According to its website, AP's vision is: To innovate to bring therapies to patients that significantly improve their lives.' AP's Staff Code of Conduct states: Our priorities are ensuring the safety and protecting the rights of those who take part in our clinical trials and upholding the highest ethical, scientific, and medical standards in all our research and development activities. The company has enjoyed a surge in demand for vaccine production because of the pandemic. Henry Blake (Blake) has been the director of the Research and Development Division (R&D Division) for the past 25 years. He is more experienced in vaccine development, production, and quality control than anyone else in the entire company. He will be retiring in two weeks' time. Unbeknownst to directors outside the R&D Division, Blake and his teams have been trialling experimental vaccines on people from rural Uganda for the past decade. This has proved to be considerably more cost effective than trialling the vaccines in Australia, where participants demand up to $10,000 per drug trialled and participants who experience serious side-effects or death are entitled to millions of dollars in compensation. Participants in rural Uganda require only $5 per drug trialled, and never sue. Furthermore, it is illegal to trial experimental vaccines on pregnant women in Australia, but there are no such laws in Uganda, and pregnant women are apparently very willing to participate in the company's trials. AP has been able to bring to market several vaccines that are deemed to be 'safe for pregnant women' because of Blake's approach, including a new COVID 19 vaccine. Through his leadership of the R&D Division, Blake has contributed more than $400 million Canterbury Institute of Management, 41 Mclaren Street, NORTH SYDNEY NSW 2060 Australia Phone: +61 2 8007 5846 Fax: +61 2 9280 3858 Website: https://ciom.edu.au/ MGMT20| Organisational Behaviour Page I of 3 to the company's billion-dollar profits each year for the past decade. Last week, The Australian newspaper ran a story about 'human rights violations in the pharmaceutical industry' and named AP as one of the biggest offenders. The article urged Australians not to get AP's new COVID19 vaccine because it would be 'a vote against human rights.' The story is trending on social media and the director of marketing advises that the story is set to create an international public relations disaster that will jeopardise the company's sales of the COVID19 vaccine. Moreover, if the Australian Government loses confidence in the company, it may not approve other new drugs for which the company will need regulatory approval. Blake admits that the story is true but says he can't see any problem with what he has been doing, because it is very cost effective and there are 'no human rights laws in Australia or in Uganda.' Every person of colour who has ever been assigned to Blake's Division has resigned within weeks. Pregnant women refuse to work in his division. Currently, all staff in Blake's Division are males over 40 years of age. Staff feedback surveys from the R&D Division from the last 10 years show that Blake's staff are generally happy and have confidence in Blake, which Blake says 'proves beyond doubt' that he is an outstanding leader. At his retirement party last week, Blake gave a speech in which he said he takes 'full credit' for the huge profits generated by the R&D Division, and he hopes that the new director will be 'as good as he is,' otherwise the company is in 'big trouble.' I. How does the quotation below apply to Blake? In your answer discuss context, perception and active listening. Justify your answer by reference to theories and concepts studied in this course. What you see and hear depends a good deal on where you are standing; it also depends on what sort of person you are.' - C.S. Lewis |ALL QUESTIONS RELATE TO THE FOLLOWING SCENARIO: Aussie Pharmaceuticals Led (AP) is Australia's largest pharmaceutical company, which employs over 10,000 workers. According to its website, AP's vision is: To innovate to bring therapies to patients that significantly improve their lives.' AP's Staff Code of Conduct states: 'Our priorities are ensuring the safety and protecting the rights of those who take part in our clinical trials and upholding the highest ethical, scientific, and medical standards in all our research and development activities.' The company has enjoyed a surge in demand for vaccine production because of the pandemic. Henry Blake (Blake) has been the director of the Research and Development Division (R&D Division) for the past 25 years. He is more experienced in vaccine development, production, and quality control than anyone else in the entire company. He will be retiring in two weeks' time. Unbeknownst to directors outside the R&D Division, Blake and his teams have been trialling experimental vaccines on people from rural Uganda for the past decade. This has proved to be considerably more cost effective than trialling the vaccines in Australia, where participants demand up to $10,000 per drug trialled and participants who experience serious side-effects or death are entitled to millions of dollars in compensation. Participants in rural Uganda require only $5 per drug trialled, and never sue. Furthermore, it is illegal to trial experimental vaccines on pregnant women in Australia, but there are no such laws in Uganda, and pregnant women are apparently very willing to participate in the company's trials. AP has been able to bring to market several vaccines that are deemed to be 'safe for pregnant women' because of Blake's approach, including a new COVID 19 vaccine. Through his leadership of the R&D Division, Blake has contributed more than $400 million to the company's billion-dollar profits each year for the past decade. Last week, The Australian newspaper ran a story about 'human rights violations in the pharmaceutical industry' and named AP as one of the biggest offenders. The article urged Australians not to get AP's new COVID19 vaccine because it would be 'a vote against human rights.' The story is trending on social media and the director of marketing advises that the story is set to create an international public relations disaster that will jeopardise the company's sales of the COVID19 vaccine. Moreover, if the Australian Government loses confidence in the company, it may not approve other new drugs for which the company will need regulatory approval. Blake admits that the story is true but says he can't see any problem with what he has been doing, because it is very cost effective and there are 'no human rights laws in Australia or in Uganda.' Every person of colour who has ever been assigned to Blake's Division has resigned within weeks. Pregnant women refuse to work in his division. Currently, all staff in Blake's Division are males over 40 years of age. Staff feedback surveys from the R&D Division from the last 10 years show that Blake's staff are generally happy and have confidence in Blake, which Blake says 'proves beyond doubt' that he is an outstanding leader. At his retirement party last week, Blake gave a speech in which he said he takes 'full credit' for the huge profits generated by the R&D Division, and he hopes that the new director will be 'as good as he is,' otherwise the company is in 'big trouble." 1. Is Blake a 'participative decision maker'? Use evidence to support your answer. Critically discuss the advantages and disadvantages of participative decision making in relation to the R&D Division and explain how you would be a more participative decision-maker if you were appointed to replace Blake